CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies
Pharmacy Times
JUNE 19, 2025
With annual growth projected at 36% through 2030 and 10 to 20 new approvals expected each year, oncology pharmacists are likely to encounter these therapies more frequently across care settings. 2-4 In the United States, the FDA had approved 44 cell therapy products as of March 6, 2025. Trends Pharmacol Sci. 2024;45(5):406-418.
Let's personalize your content